gut microbiota
Key areas of interest include circadian rhythms, neurological conditions, metabolic disorders, and oncology.
The findings of a recent study suggest that Desulfovibrio can drive cancer progression, paving the way for therapeutic approached that targeting the gut microbiota.
The authors advocate for further research on worm-microbiota interactions, suggesting that new animal models could help inform strategies for improving health during early life.
The findings uncover a link between vitamin D, the immune system and gut bacteria, and they suggest that vitamin D levels could be important for cancer immunity and the efficacy…
The findings of a recent study show that Q-net can accurately predict the long-term trajectories of gut microbes and identify patterns indicative of future cognitive deficits.
The findings of a recent study suggest that the infant gut microbiota begins to develop circadian rhythms soon after birth, with diet having minimal influence on these microbial patterns.
VOWST is the first and only orally administered microbiota-based therapeutic approved by the U.S. FDA for the prevention of recurrent Clostridioides difficile infection in adults.
The findings of a recent study reveal how gut bacteria modify immune molecules in ways that lead to the development of IgA nephropathy.
The findings of a recent study suggest that Ruminococcus bacteria were more prevalent in ancient human populations and non-industrialized societies, likely due to the high dietary fiber intake.
The findings of a recent study suggest that the infant microbiota produces neurotransmitters that are required for the development of the immune system.
